Lamotrigine PreSolicitation   3

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lamotrigine ER Tablets. Procurement details follow.
Lamotrigine ER: 25MG, 50MG, 100MG, 200MG, 250MG and 300MG tablets in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Bureau of Prisons, Indian Health Service and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Nancy Fernandez at (215) 737-4955 or Nancy.Fernandez@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is November of 2024. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

Background
The solicitation is issued by the Defense Logistics Agency (DLA) for the procurement of Lamotrigine, a medication used to treat epilepsy and bipolar disorder. The goal of the contract is to ensure a reliable supply of this essential pharmaceutical product to meet the needs of government healthcare facilities.

Work Details
The contract includes the following items with specified quantities and packaging:

1. **Lamotrigine ER 24 25MG – 30 Count**
- Base Year: 3,216 BTL
- Option Year 1: 3,216 BTL
- Option Year 2: 3,216 BTL
- Option Year 3: 3,216 BTL
- Option Year 4: 3,216 BTL

2. **Lamotrigine ER 24 50MG – 30 Count**
- Base Year: 7,895 BTL
- Option Year 1: 7,895 BTL
- Option Year 2: 7,895 BTL
- Option Year 3: 7,895 BTL
- Option Year 4: 7,895 BTL

3. **Lamotrigine ER 24 100MG – 30 Count**
- Base Year: 11,904 BTL
- Option Year 1: 11,904 BTL
- Option Year 2: 11,904 BTL
- Option Year 3: 11,904 BTL
- Option Year 4: 11,904 BTL

4. **Lamotrigine ER 24 200MG – 30 Count**
- Base Year: 15,775 BTL
- Option Year 1: 15,775 BTL
- Option Year 2: 15,775 BTL
- Option Year 3: 15,775 BTL
- Option Year 4: 15,775 BTL

5. **Lamotrigine ER 24 250MG – 30 Count**
- Base Year: 3,734 BTL
- Option Year 1: 3,734 BTL
- Option Year 2: 3,734 BTL
- Option Year 3: 3,734 BTL
- Option Year 4: 3,734 BTL

6. **Lamotrigine ER 24 300MG –30 Count**
- Base Year:7,510 BTL
- Option Year1 :7 ,510BTL
... (similar for other years)
*BTL = ONE (1) bottle; Packaging size is subject to Statement of Work requirements.

Period of Performance
The period of performance for this contract spans from November25 ,2024 to January9 ,2025.

Place of Performance
Products will be delivered to designated government healthcare facilities as specified in the solicitation.